Clinical Trial

EUS-DFI in Solid Pancreatic Lesions

Study acronym: DFI
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This prospective, international, multicenter observational study aims to evaluate the role of Endoscopic Ultrasound-guided Detective Flow Imaging (EUS-DFI) in the characterization of solid pancreatic lesions. The study will assess microvascularization patterns identified by EUS-DFI and their association with the final diagnosis, using histopathology or clinical follow-up as the reference standard. Secondary objectives include evaluating interobserver agreement and the diagnostic accuracy of DFI vascular patterns for differentiating benign and malignant pancreatic lesions.
Trial Details
NCT Number NCT07763561
Lead Sponsor Julio Iglesias García
Collaborators: Ospedale San Raffaele, Università Vita Salute San Raffaele, Policlinico Universitario Campus Bio-Medico, Leids Universitair Medisch Centrum (LUMC), Leiden
Conditions Pancreatic Neoplasms, Pancreatic Solid Lesions
Enrollment 48 participants
Start Date 2026-12-01
Primary Completion 2027-06-01 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-13